[Myasthenia gravis].
D000085:Acetates / Q000627:therapeutic use; D000328:Adult; D002118:Calcium / Q000627:therapeutic use; D002648:Child; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use; D005260:Female; D006146:Guanidines / Q000627:therapeutic use; D006728:Hormones / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000188:drug therapy; D007328:Insulin / Q000627:therapeutic use; D009157:Myasthenia Gravis / Q000150:complications / Q000188:drug therapy* / Q000601:surgery / Q000628:therapy; D007744:Obstetric Labor Complications / Q000628:therapy; D010060:Ovulation; D011188:Potassium / Q000627:therapeutic use; D011247:Pregnancy; D012469:Salivary Glands / Q000378:metabolism; D013934:Thymectomy
D000085:Acetates; D002800:Cholinesterase Inhibitors; D006146:Guanidines; D006728:Hormones; D007166:Immunosuppressive Agents; D007328:Insulin; D011188:Potassium; D002118:Calcium